Skip to main content

Table 2 Association between clinical variables and serum HER2 levels

From: Association between serum HER2/ErbB2 levels and coronary artery disease: a case–control study

 

Entire study population

CAD group

Control group

β coefficient

95% CI

P

β coefficient

95% CI

P

β coefficient

95% CI

P

Age

− 0.158

− 0.272 to − 0.044

0.007

− 0.112

− 0.298 to 0.075

0.240

− 0.257

− 0.395 to − 0.119

< 0.001

Male gender

0.048

− 0.171 to 0.268

0.665

− 0.202

− 0.559 to 0.155

0.265

0.205

− 0.059 to 0.470

0.127

BMI

0.212

0.114 to 0.310

< 0.001

0.335

0.183 to 0.487

< 0.001

0.133

0.008 to 0.257

0.037

Current smoking

0.164

− 0.059 to 0.387

0.149

0.287

− 0.032 to 0.606

0.078

− 0.088

− 0.392 to 0.215

0.567

Hypertension

− 0.174

− 0.360 to 0.012

0.067

− 0.297

− 0.588 to − 0.007

0.045

− 0.096

− 0.324 to 0.132

0.408

HbA1c

0.086

− 0.005 to 0.176

0.064

0.032

− 0.090 to 0.154

0.607

0.093

− 0.053 to 0.238

0.210

LDL-C

0.180

0.090 to 0.269

< 0.001

0.106

− 0.022 to 0.234

0.106

0.218

0.085 to 0.351

0.001

HDL-C

0.082

− 0.010 to 0.175

0.080

0.013

− 0.106 to 0.132

0.835

0.172

− 0.007 to 0.351

0.060

Triglycerides

0.184

0.092 to 0.276

< 0.001

0.175

0.049 to 0.301

0.007

0.197

0.053 to 0.341

0.008

eGFR

− 0.021

− 0.126 to 0.085

0.697

0.067

− 0.081 to 0.216

0.372

− 0.084

− 0.235 to 0.067

0.271

  1. Multivariate linear regression analysis with HER2 levels as a dependent variable in the entire study population, CAD group, and control group, respectively. The β coefficient for the continuous variables is expressed as per 1-SD increase to allow comparison among effects
  2. BMI body mass index, CI confidence interval, eGFR estimated glomerular filtration rate, HbA1c hemoglobin A1c, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol